This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

IMAAVY™ (nipocalimab-aahu)

Medical Information

IMAAVY - Stability of Diluted Solution for Intravenous Infusion

Last Updated: 04/30/2025

Summary

  • The company cannot recommend any practices, procedures, or usage that deviate from the approved labeling.
  • Please refer to the local labeling for further information on preparation and stability of IMAAVY.

PRESCRIBING INFORMATION

PREPARATION AND ADMINISTRATION INSTRUCTIONS

Preparation

Storage Conditions of the Diluted Solution1 
  • Administer the diluted IMAAVY solution immediately after preparation.
  • If the diluted IMAAVY solution is not used immediately:
    • Protect from light.
    • Store refrigerated at 2°C to 8°C (36°F to 46°F) for no more than 24 hours.
    • Do not freeze.
    • After preparation or removal from the refrigerator, use or discard the IMAAVY diluted solution within 12 hours, including infusion time. During these 12 hours, store under ambient light at 15°C to 30°C (59°F to 86°F).

 

References

1 IMAAVY (nipocalimab-aahu) [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc;https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/IMAAVY-pi.pdf